v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 4,055 $ 8,482
Short-term investments 5,862  
Accounts receivable 691 1,253
Other current assets 705 2,477
Total current assets 11,313 12,212
Property and equipment, net 38 73
Operating lease assets 6,494 7,064
Other assets 762 886
Total assets 18,607 20,235
Current liabilities:    
Accounts payable 762 127
Accrued compensation 471 1,271
Accrued research and development expenses 24 82
Deferred revenue 513 716
Liability related to the sale of future revenues - current portion 1,105 9,750
Other current liabilities 3,693 2,976
Total current liabilities 6,568 14,922
Operating lease liabilities - long-term 8,482 9,347
Liability related to the sale of future revenues - long-term 39,560 32,673
Other long-term liabilities 1,899 1,795
Total liabilities 56,509 58,737
Commitments and contingencies (Note 9)
Stockholders' equity (deficit):    
Common stock-$0.0001 par value, 500,000 shares authorized as of September 30, 2026 and December 31, 2025; 10,188 and 7,324 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively 1 1
Additional paid-in capital 1,995,171 1,983,361
Accumulated other comprehensive income (loss) (1) 1
Accumulated deficit (2,033,073) (2,021,865)
Total stockholders' equity (deficit) (37,902) (38,502)
Total liabilities and stockholders' equity (deficit) $ 18,607 $ 20,235

Source

10-Q
HTML PDF
XBRL
ZIP